Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07090005 · ClinicalTrials.gov registry record · NA

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

A NA study of Obesity and Overweight, sponsored by Nitinotes Surgical.

Recruiting
Registry status
NA
Development phase
184
Enrollment target
2
Study locations

NCT07090005: Recruiting NA study of Obesity and Overweight, sponsored by Nitinotes Surgical.

NCT07090005 is a NA study of Obesity and Overweight that is actively recruiting participants, run by Nitinotes Surgical. The registered enrollment target is 184 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07090005, a NA study of Obesity and Overweight, is actively recruiting participants, sponsored by Nitinotes Surgical.

RECRUITING
Registry status
NA
Development phase
184 participants
Enrollment target
2
Study locations

Study Summary

evaluation of the EndoZip system procedure compared to the Apollo ESG procedure in obese patients.

Conditions Studied

Interventions

  • DEVICE EndoZip System
  • DEVICE OverStitch Endoscopic Suturing System (ESG)

Study Locations (2)

California

  • Cedars Sinai Medical Center - Los Angeles

New York

  • Lenox Hill Hospital | Northwell Health - New York

Trial Details

FieldValue
Enrollment Target 184 participants
Start Date 2025-11-14
Est. Completion 2027-07-01
Phase NA

Sponsor

Nitinotes Surgical

1 total trials

What the Registry Record Tells You About NCT07090005

The ClinicalTrials.gov registry entry for NCT07090005 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 184 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (78% lower). The listed sponsor is Nitinotes Surgical, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which EndoZip System is the first listed.

NCT07090005 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, New York.

Frequently Asked Questions

What is clinical trial NCT07090005 about?

NCT07090005 is a clinical study titled "Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients". evaluation of the EndoZip system procedure compared to the Apollo ESG procedure in obese patients.

What is the current status of trial NCT07090005?

This trial is currently recruiting. It is a NA study. The enrollment target is 184 participants. The study started on 2025-11-14. Estimated completion is 2027-07-01.

What conditions does trial NCT07090005 study?

This clinical trial studies the following conditions: Obesity, Overweight.

What interventions are being tested in trial NCT07090005?

The interventions under investigation include: EndoZip System (DEVICE), OverStitch Endoscopic Suturing System (ESG) (DEVICE).

Who is sponsoring clinical trial NCT07090005?

This trial is sponsored by Nitinotes Surgical, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07090005 being conducted?

This trial has 2 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.